ScienceDex / Researcher record
Ryu, Hanjoon
- Unknown Institution (no department on record)
From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.
- Top 1% Funded
- Early Career
NIH Funding · FY2021
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2021 | $24,361,759 | 1 | #57 |
| 2022 | $4,158,139 | 1 | #994 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2021 · selected1 record
- FY20221 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2021 award records by amount
NIH award records listing Ryu, Hanjoon as a PI. Multi-PI records show the full award amount for context.
- 75N92021C00008-0-9999-1N02Contact PIAWARD A CONTRACT FOR RADX TECH - QORVO TO SECURE AN EUA APPROVED POC ANTIGEN TEST SYSTEM AS WELL AS INCREASE AN INCREMENTAL DAILY CARTRIDGE PRODUCTION$24.4Maward amount
Award organization
Organizations that administered FY2021 awards listing Ryu, Hanjoon as a PI.
FY2021 award administered by Unknown Institution ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardUnknown Institution
- 2021$500K Cumulative Funding
- 2021$1M Cumulative Funding
- 2021$2M Cumulative Funding
- 2021$5M Cumulative Funding
- 2021$10M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #57
- 2021Entered Top 25% NationallyRanked #57
- 2021Entered Top 10% NationallyRanked #57
- 2021Entered Top 5% NationallyRanked #57
- 2021Entered Top 1% NationallyRanked #57
- 2022$25M Cumulative Funding